← Open Payments lookup

JULIE SMYSER: Open Payments

NPI 1619990181 · CHARLES CITY, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$301 in 12 payments from 8 companies in 2025. Trend: 2023 $191 · 2024 $482 · 2025 $301

Food & beverage: $301
CompanyPaymentsAmount
Alkermes, Inc.1$79
Takeda Pharmaceuticals U.S.A., Inc.3$67
Vanda Pharmaceuticals Inc.2$53
ABBVIE INC.2$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20
Biogen, Inc.1$19
Otsuka America Pharmaceutical, Inc.1$19
Supernus Pharmaceuticals, Inc.1$15

Products named: ARISTADA, TRINTELLIX, FANAPT, VRAYLAR, HETLIOZ, CAPLYTA, ZURZUVAE, REXULTI.

Industry payments across VA — which companies pay providers there.